International Flavors & Fragrances exceeded Q1 sales and profit expectations, bolstered by robust demand for its food ingredients. This strong performance signals IFF's competitive advantage and could enhance investor confidence in its growth outlook.
IFF divested its soy crush and lecithin business. Analyst Ivan Feinseth maintains a buy rating with a $105 target. TipRanks' AI Analyst has a neutral rating with a target of $65. IFF focuses on high-margin, health-oriented products and portfolio optimization. The company authorized a new $500 million share repurchase program.
IFF reported Q1 earnings of $1.20, exceeding estimates of $1.14. Sales of $2.84 billion also beat the consensus estimate of $2.83 billion. CEO highlighted growth due to productivity initiatives and broad-based business growth. IFF affirmed FY2025 sales guidance of $10.60 billion to $10.90 billion. Barclays upgraded IFF to Overweight, raising the price target to $84.